Skip to navigation Skip to content

The Cancer Letter

Inside information on cancer research and drug development

  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
  • Current Issue
    • Past Issues
  • Events
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter

The Cancer Letter

Inside information on cancer research and drug development

  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
  • Current Issue
    • Past Issues
  • Events
Vol.
43
No.
43
November 17, 2017Nov 17, 2017
DOWNLOAD PDF
Cover Story
Defining the next level for Inova
By Paul Goldberg
Second story in a three-part series

Caligiuri resigns as CEO of the James after stepping down as director of OSUCCC

By Matthew Bin Han Ong
FreeObituary

Hail to “The Chief” Donald S. Coffey, a scientist, a mentor, a wit, dies at 85

By Kenneth J. Pienta and Matthew Bin Han Ong

In Brief

De la Chapelle receives lifetime achievement award from colorectal cancer group
Gallagher named vice president and head of Global Oncology Development at AbbVie
Sylvester geneticist Shiekhattar receives NIH “Pioneer Award”
WPI's Mattson receives $1.7-million NIH award to develop molecular methods
LUNGevity partners with ALK Positive Patient Group to fund research

Drugs & Targets

FDA approves adjuvant indication for Sutent in renal cell carcinoma
FDA approves obinutuzumab for previously untreated follicular lymphoma
FDA approves Sprycel for pediatric patients with CML
FDA approves Genentech's Hemlibra to prevent bleeding in hemophilia A
FDA authorized MSKCC's tumor profiling tests
PREVIOUS ISSUE
NEXT ISSUE

Recent Issues

Apr 09, 2021
Apr 02, 2021
Mar 26, 2021
Mar 19, 2021
Mar 12, 2021
Mar 05, 2021
VIEW MORE

Trending Stories

  • Narjust Duma named associate director of the Cancer Care Equity Program at DFCI, Harvard Medical School
  • Robert Stone: City of Hope aims to transform cancer care nationally through new models, partnerships
  • Biden commits to creating “ARPA-H” research body in visit to Ohio State
  • Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
  • The Cancer Letter gets a new website
  • Abecma receives FDA approval for multiple myeloma
ABOUT
ABOUT
About The Cancer Letter
Our Contributors
Editorial policies
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2021 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Twitter
LinkedIn
Facebook
Vimeo
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Request Cancellation
Login

Forgot your password?

Looking for IP Login?

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No